P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results
- 1 June 2001
- journal article
- Published by Springer Nature in Magnetic Resonance Materials in Physics, Biology and Medicine
- Vol. 12 (2-3) , 121-127
- https://doi.org/10.1007/bf02668093
Abstract
An original MRI contrast agent, called P792, is described. P792 is a gadolinium macrocyclic compound based on a Gd-DOTA structure substituted by hydrophilic arms. The chemical structure of P792 has been optimized in order to provide (1) a high r1 relaxivity in the clinical field for MRI: 29 mM−1 x s−1 at 60 MHz. (2) a high biocompatibility profile and (3) a high molecular volume: the apparent hydrodynamic volume of P792 is 125 times greater than that of Gd-DOTA. As a result of this high molecular volume, P792 presents an unusual pharmacokinetic profile, as it is a Rapid Clearance Blood Pool Agent (RCBPA) characterized by limited diffusion across the normal endothelium. The original pharmacokinetic properties of this RCBPA are expected to be well suited to MR coronary angiography, angiography, perfusion imaging (stress and rest), and permeability imaging (detection of ischemia and tumor grading). Further experimental imaging studies are ongoing to define the clinical value of this compound.Keywords
This publication has 36 references indexed in Scilit:
- Pharmacokinetics of Three Gadolinium Chelates with Different Molecular Sizes Shortly After Intravenous Injection in RabbitsInvestigative Radiology, 2000
- Kinetic characterization of CMD-A2-Gd-DOTA as an intravascular contrast agent for myocardial perfusion measurement with MRIMagnetic Resonance in Medicine, 2000
- Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphographyAdvanced Drug Delivery Reviews, 1999
- Structure and dynamics of all of the stereoisomers of europium complexes of tetra(carboxyethyl) derivatives of dota: ring inversion is decoupled from cooperative arm rotation in the RRRR and RRRS isomersChemical Communications, 1998
- Macromolecular systems for chemotherapy and magnetic resonance imagingAdvanced Drug Delivery Reviews, 1996
- Gd‐DTPA‐cascade‐polymer: Potential blood pool contrast agent for MR imagingJournal of Magnetic Resonance Imaging, 1994
- A kinetic investigation of the lanthanide DOTA chelates. Stability and rates of formation and of dissociation of a macrocyclic gadolinium(III) polyaza polycarboxylic MRI contrast agentInorganic Chemistry, 1992
- Rationale and applications for macromolecular Gd‐based contrast agentsMagnetic Resonance in Medicine, 1991
- Albumin Labeled with Gd-DTPAInvestigative Radiology, 1987
- Thermodynamic study of lanthanide complexes of 1,4,7-triazacyclononane-N,N',N"-triacetic acid and 1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acidInorganic Chemistry, 1987